16 MARCH 2020 Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutical has partnered with the Beth Israel Deaconess Medical Center (BIDMC) to advance Covid-19 vaccine development. The partners started pre-clinical testing of different vaccine prospects. The aim is to select a vaccine candidate for clinical trials by the end of this month. Janssen expects to launch …